MORGAN STANLEY - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 22 filers reported holding BENITEC BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$9,206
-3.6%
38,600
-15.2%
0.00%
Q1 2023$9,550
-84.8%
45,500
-87.7%
0.00%
Q4 2022$62,717
+124.0%
368,923
+385.5%
0.00%
Q3 2022$28,000
+300.0%
75,994
+1210.2%
0.00%
Q2 2022$7,0005,800
+5700.0%
0.00%
Q1 2022$0
-100.0%
100
-99.9%
0.00%
Q1 2021$438,000
+1023.1%
84,725
+549.0%
0.00%
Q4 2020$39,000
-82.2%
13,054
-62.5%
0.00%
Q3 2020$219,000
-5.6%
34,838
+18.7%
0.00%
Q2 2020$232,00029,3380.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$161,4130.01%
Virtu Financial LLC 121,514$260.00%
WealthTrust Axiom LLC 12,950$2,7180.00%
FRANKLIN RESOURCES INC 10,000,000$2,099,0000.00%
Walleye Capital LLC 215,989$45,3360.00%
UBS Group AG 347$730.00%
TWO SIGMA INVESTMENTS, LP 26,747$5,6140.00%
WELLS FARGO & COMPANY/MN 193$410.00%
NORTHERN TRUST CORP 11,813$2,4800.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BENITEC BIOPHARMA INC shareholders